LONDON and GENEVA -- A new strategy to fight one of the world's leading killers - tuberculosis (TB) - was launched today by the World Health Organization (WHO).
The new "Stop TB Strategy" addresses the current challenges facing countries in responding to TB -- how to continue scaling-up TB control activities while also addressing the spread of TB and HIV co-infection and multidrug-resistant TB (MDR-TB). Both TB/HIV, especially in Africa, and MDR-TB, particularly in Eastern Europe, are seriously hampering global control efforts to reduce the 1.7 million deaths caused by TB every year.
At the strategy's core is DOTS, the TB control approach launched by WHO in 1995. Since its launch, more than 22 million patients have been treated under DOTS-based services. The new six-point strategy builds on this success, while recognizing the key challenges of TB/HIV and MDR-TB. It also responds to access, equity and quality constraints, and adopts evidence-based innovations in engaging with private healthcare providers, empowering affected people and communities and helping to strengthen health systems and promote research.
"DOTS remains central to TB control. Without it we would have no TB control. But with DOTS programs now established in 183 countries, the new Stop TB Strategy injects new energies to make efforts more comprehensive and effective," said Dr. Mario Raviglione, director of WHO's Stop TB Department. "The Stop TB Strategy aims to ensure access to care for all TB patients, to reach the 2015 Millennium Development Goal for TB and to reduce the burden of TB worldwide."
The Stop TB Strategy, published in the 17 March issue of The Lancet, was developed during a consultation process involving international health partners over a two-year period. Its six components are:
1. Pursuing high-quality DOTS expansion and enhancement. Making high-quality services widely available and accessible to all those who need them, including the poorest and most vulnerable, requires DOTS expansion to even the remotest areas.
2. Addressing TB/HIV, MDR-TB and other challenges. Addressing TB/HIV, MDR-TB and other challenges requires much greater action and input than DOTS implementation and is essential to achieving the targets set for 2015, including the United Nations Millennium Development Goal relating to TB (Goal 6; Target 8).
3. Contributing to health system strengthening. National TB control programs must contribute to overall strategies to advance financing, planning, management, information and supply systems and innovative service delivery scale-up.
4. Engaging all care providers. TB patients seek care from a wide array of public, private, corporate and voluntary healthcare providers. To be able to reach all patients and ensure that they receive high-quality care, all types of healthcare providers are to be engaged.
5. Empowering people with TB, and communities. Community TB care projects have shown how people and communities can undertake some essential TB control tasks. These networks can mobilize civil societies and also ensure political support and long-term sustainability for TB control programs.
6. Enabling and promoting research. While current tools can control TB, improved practices and elimination will depend on new diagnostics, drugs and vaccines.
 The new Stop TB Strategy underpins the Global Plan to Stop TB, 2006-2015, an ambitious $56 billion action plan launched in January. If fully implemented, the Global Plan will treat 50 million people for TB, halve TB prevalence and death rates and save 14 million lives.
Source: World Health Organization
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.